Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (2024)

Delayed Deutsche Boerse AG

Other stock markets

03:15:02 2024-06-28 am EDT
5-day change 1st Jan Change
0.03 EUR 0.00% Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (1) -7.69% +93.55%
Jun. 27 EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens AN
Jun. 27 Genflow Biosciences plc Announces Strengthening of Pre-Clinical Efforts CI

Financials

Sales 2022 - Sales 2023 - Capitalization 4.17M 3.89M
Net income 2022 -1M -934K Net income 2023 -1M -934K EV / Sales 2022 -
Net cash position 2022 2.36M 2.2M Net cash position 2023 684K 639K EV / Sales 2023 -
P/E ratio 2022

-5.26x

P/E ratio 2023

-2.56x

Employees 5
Yield 2022 *

-

Yield 2023

-

Free-Float 36.13%

More Fundamentals * Assessed data

Chart Genflow Biosciences plc

Dynamic Chart

Latest news about Genflow Biosciences plc

EARNINGS AND TRADING: Shuka Minerals loss narrows; Atome loss widens AN
Genflow Biosciences plc Announces Strengthening of Pre-Clinical Efforts CI
EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant AN
Genflow Biosciences receives 50% of grant for sarcopenia project AN
Genflow Biosciences Secures Grant for Sarcopenia Research Program MT
Home REIT cuts borrowings, Genflow shares restored AN
Genflow Biosciences Resumes London Trading MT
EARNINGS AND TRADING: Solid State and MTI Wireless win deals AN
Genflow Biosciences plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Genflow Biosciences to Temporarily Halt Trading Amid Delay in FY23 Results Publication MT
Northcoders launches bootcamp; Schroder invests AN
Genflow Biosciences Raises New Funds for Liver Disease Treatment Trials MT
Genflow confirms publication of European patent for SIRT6 AN
Genflow wins new research grants; Seeen margin rises AN
Coro Energy strikes finance deal in Vietnam AN

More news

Press releases Genflow Biosciences plc

Genflow Biosciences advances three major programs in fight against ageing diseases AQ
Genflow Biosciences attracts new institutional investors with £715,000 fundraise AQ
Genflow Biosciences Plc to Present Live at the Virtual Life Science Investor Forum March 7th AQ
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024 AQ
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024 GL

More press releases

Quotes and Performance

1 week-7.69%
Current month-10.45%
1 month-10.45%
3 months+81.82%
6 months+93.55%
Current year+93.55%

More quotes

Highs and lows

1 week

0.02

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (2)

0.03

1 month

0.02

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (3)

0.04

Current year

0.01

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (4)

0.04

1 year

0.01

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (5)

0.04

3 years

0.01

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (6)

0.16

5 years

0.01

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (7)

0.16

10 years

0.01

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (8)

0.16

More quotes

Managers and Directors - Genflow Biosciences plc

Managers TitleAgeSince

Eric Jean Marie Leire FOU

Founder 66 19-12-31
Members of the board TitleAgeSince

Guy-Charles Fanneau de la Horie BRD

Director/Board Member 64 22-06-28

Tamara Joseph CHM

Chairman 61 22-06-28

Eric Jean Marie Leire FOU

Founder 66 19-12-31

More insiders

Quotes

Date Price Change
24-06-28 0.03 0.00%
24-06-27 0.03 +3.45%
24-06-26 0.029 -3.33%
24-06-25 0.03 0.00%
24-06-24 0.03 -7.69%

Delayed Quote Deutsche Boerse AG, June 28, 2024 at 03:15 am EDT

More quotes

Company Profile

Genflow Biosciences Plc is a United Kingdom-based biotechnology company. The Company is engaged in developing gene therapies designed to target the aging process and to reduce and delay the incidence of age-related diseases, which is done through therapeutics targeting aging in humans by using adeno-associated virus (AAV) vectors to deliver copies of the Sirtuin-6 (SIRT6) gene variant that is found in centenarians into cells. The Company's product line includes GF-1002, GF-3001 and GF-4001. GF-4001. GF-1002 is a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. GF-4001 is a non-human version of GF-1002 anti-ageing gene therapy developed for veterinary use (dogs). GF-3001 is a formulation of an adeno-associated viral vector-based gene therapy. The Company has operations in the United Kingdom and Belgium.

Sector

Calendar

2024-09-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Therapeutic Drugs

1st Jan change Capi.

VERTEX PHARMACEUTICALS INCORPORATED

+16.13% 122B

REGENERON PHARMACEUTICALS, INC.

+19.65% 113B

ARGENX SE

+20.67% 26.49B

BIONTECH SE

-23.84% 19.4B

GENMAB A/S

-17.73% 16.24B

WUXI APPTEC CO., LTD.

-45.95% 15.15B

BEIGENE, LTD.

-19.28% 15.4B

SAREPTA THERAPEUTICS, INC.

+63.81% 14.93B

NEUROCRINE BIOSCIENCES, INC.

+1.94% 13.52B

Bio Therapeutic Drugs

  1. Stock Market
  2. Equities
  3. GENF Stock
  4. WQ5 Stock
Our Free Content Help you Secure and Increase the Performance of Your Investments Securing my Investments

Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (18)

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '132783668');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
Genflow Biosciences plc Stock (WQ5) - Quote Deutsche Boerse AG- MarketScreener (2024)

References

Top Articles
Latest Posts
Article information

Author: Duane Harber

Last Updated:

Views: 6462

Rating: 4 / 5 (71 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Duane Harber

Birthday: 1999-10-17

Address: Apt. 404 9899 Magnolia Roads, Port Royceville, ID 78186

Phone: +186911129794335

Job: Human Hospitality Planner

Hobby: Listening to music, Orienteering, Knapping, Dance, Mountain biking, Fishing, Pottery

Introduction: My name is Duane Harber, I am a modern, clever, handsome, fair, agreeable, inexpensive, beautiful person who loves writing and wants to share my knowledge and understanding with you.